Univdatos Whatsapp
Drug Screening Market

Global Drug Screening Market is expected to foresee significant growth during the forecast period. North America to witness the highest growth

Global Drug Screening Market is expected to reach the market valuation of USD XX billion by 2027 expanding at a reasonable CAGR of XX% during the forecast period (2021-2027) from USD XX billion in 2020. Drug screening is a method of detecting illegal and prescription drugs in blood, urine, and other bodily fluids. It’s also used to figure out how much of a drug you’re using, and it’s an important aspect of continuing evaluation and treatment.

The increased consumption of alcohol worldwide has increased the demand for drug screening tests. For instance, as per American Addiction Centers Alcohol.org on average, citizens of Belarus consume 14.4 liters each year, over 1.5 times more than Americans. Russia, known for its heavy consumption of vodka, drank an average of 11.5 liters of pure alcohol each year, less than the average of five other countries. Moreover, Ireland, Luxembourg, and Slovakia consumed slightly less, all drinking an average of 11.4 liters per capita. The U.S. claimed the 25th spot, drinking an average of 8.7 liters of pure alcohol per capita annually.

For a detailed analysis of the Drug Screening browse through – https://univdatos.com/report/drug-screening-market/

Furthermore, in 2020, it was estimated that around 5.4% of the global population uses illicit drugs. The use of illicit drugs varies by country and region as countries enact their laws regarding such substances. Worldwide, cannabis is by far the most used type of illicit drug, followed by opioids and amphetamines. Furthermore, as per World Drug Report, the practice of injecting drugs accounted for roughly 10% of HIV infections worldwide in 2018. Out of which, more than 1 million people who inject drugs have been living with HIV and 5.5 million are living with hepatitis C.

The COVID19 has resulted in a profound re-evaluation of the advantages and costs of Drug Screening. The COVID-19 pandemic has disrupted health systems worldwide. This has had a profound impact on drug screening tests. Due to limited or non-availability of medical facilities/treatment centers, harm reduction service providers, and the fear of infection transmission, it has caused significant disruptions to businesses and economic activities around the world, and it is expected to have a short-term negative impact on the drug screening market. A recent survey performed by the Current Consulting Group (CCG) in 2021, found that since the start of the pandemic, 21% of employers have reported a drop of 61% or more in the number of drug tests that they perform on employees in the US states.

For a detailed analysis of the COVID-19 Impact on Drug Screening browse through – https://univdatos.com/report/drug-screening-market/

Furthermore, various governments around the world have issued guidelines to postpone or delay non-essential medical and surgical treatments to relieve the burden on the healthcare system and limit disease spread. Travel, company activities, public gatherings, and shelter-in-place orders were all subjected to restrictions and lockdowns, all of which hampered market expansion. For instance, following the global outbreak of COVID-19 in 2020, 68 countries restricted the export of personal protective equipment supplies to other countries, significantly disrupting the international supply chain’s distribution networks.

Based on products and services, the market is fragmented into drug screening products and drug screening services. The drug screening products segment dominated the market in 2020 and generated total revenue of USD XX billion. It is anticipated to maintain its dominance during the forecast period owing to increased applications of rapid testing devices such as urine testing devices and oral fluid testing devices.

Request for Sample of the report browse through – https://univdatos.com/get-a-free-sample-form-php/?product_id=7967

Based on the sample, the market is fragmented into urine samples, oral fluid samples, breath samples, hair samples, and other samples. The urine samples segment dominated the market in 2020 and generated total revenue of USD XX billion. It is anticipated to maintain its dominance during the forecast period owing to the benefits it offers such as high accuracy in the detection of multiple drugs, cost-effectiveness, and instant results.

Based on end-users, the market is fragmented into workplaces, drug testing laboratories, criminal justice systems & law enforcement agencies, hospitals, drug treatment centers, individual users, pain management centers, and schools & colleges. The workplace drug screening segment dominated the market in 2020 and generated total revenue of USD XX billion. It is anticipated to maintain its dominance during the forecast period because of the growing safety concerns in the workplace and the increasing number of organizations that have made regular drug screening mandatory.

Feel free to contact us for any queries – https://univdatos.com/get-a-free-sample-form-php/?product_id=7967

Additionally, the report provides detailed initiatives that are being taken in the field of Drug Screening. The market is classified into distinct regions North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), Rest of World has been conducted. North America dominated the market and generated revenue of USD XX billion in 2020 owing to the rising consumption of illicit drugs, availability of government funding to curb drug abuse, and the presence of laws supporting drug screening. However, Asia is expected to register the highest CAGR during the forecast period owing to the growing burden of accidents due to unsafe levels of alcohol consumption.

Major key players include Siemens, Thermo Fisher, LabCorp, Alere, Omega Laboratories, Roche, OraSure, Biomedical Diagnostics, Quest Diagnostics, Laboratory Corporation of America Holdings are some of the prominent players operating in the global Drug Screening market. Several M&A’s along with partnerships have been undertaken by these players to develop Drug Screening.

Global Drug Screening Market Segmentation

Market Insight, by Product and Services

  • Drug Screening Products
    • Analytical Instruments
      • Immunoassay Analyzers
      • Chromatography Instruments
      • Breathalyzers
    • Rapid Testing Devices
      • Urine Testing Devices
      • Oral Fluid Testing Devices
    • Consumables
    • Assay Kits
    • Sample Collection Tubes
    • Calibrators & Controls
    • Other Consumables
  • Drug Screening Services

Market Insight, by Sample

  • Urine Samples
  • Oral Fluid Samples
  • Breath Samples
  • Hair Samples
  • Other Samples

Market Insight, by End-Users

  • Workplaces
  • Drug Testing Laboratories
  • Criminal Justice Systems & Law Enforcement Agencies
  • Hospitals
  • Drug Treatment Centers
  • Individual Users
  • Pain Management Centers
  • Schools & Colleges

Market Insight, by Region

  • North America
    • United States
    • Canada
    • Rest of North America
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • United Kingdom
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Rest of World

Top Company Profiles

  • Siemens
  • Thermo Fisher
  • LabCorp
  •  Alere
  • Omega Laboratories
  • Roche
  • OraSure
  • Biomedical Diagnostics
  • Quest Diagnostics
  • Laboratory Corporation of America Holdings

Leave A Comment

Select Language